IA
IART
Market ClosedIntegra LifeSciences Holdings Corporation
US
4.43K employees
CEO: Stuart Essig
Founded: 1995
$19.79
+$0.00(+NaN%)
Market Cap
1.54B
Beta
1.22
52W Range
N/A
Dividend Yield
0.00%
IART Price Chart
Historical price performance
Loading MCI price data...
MarketCI Investment Signals
AI-synthesized investment signal for IART built from valuation, fundamentals, sentiment, and risk models
Investment Signal
HoldPass %
57.14%
Score
4/7
Fair Value Estimate
Cash flow analysis • Multiple methods
$20.94
AI Price Target
Machine learning • Price prediction
$18.24
Market Sentiment
News & social media analysis
0.00
Value Investor Price
Classic value analysis
$0.00
Financial Health
Bankruptcy risk assessment
0.82
Quality Score
Financial strength rating
5.00
AI Investment Grade
Deep analysis of filings & news
65.00
Key Investment Highlights
Important factors affecting IART investment thesis
Due Diligence Analysis
Investment criteria assessment and scoring
Overall Assessment
52.50% Good
Conditions Met
21.00/40.00
Due Diligence Score
52.50%Due Diligence Conditions
Investment analysis conditions and results
Pass | |
Pass | |
Fail | |
Fail | |
Fail | |
Fail |
Showing 1 to 6 of 46 conditions
Latest News
Recent news and updates for IART
No recent news available for IART
Core Financials
Loading financial data for IART...
Explore IART
IART in the Healthcare
Small Cap